Médecine

Paramédical

Autres domaines


Suscribirse

Inhibition of the growth of human dermatophytic pathogens by selected australian and asian plants traditionally used to treat fungal infections - 23/11/19

Doi : 10.1016/j.mycmed.2019.05.003 
W. Noé a, b, S. Murhekar a, c, A. White a, C. Davis d, e, I.E. Cock a, c,
a School of Environment and Science, Griffith University, 170, Kessels Rd, Nathan, 4111 Queensland, Australia 
b School of Biology, École de Biologie Industrielle (EBI), Cergy, France 
c Environmental Futures Research Institute, Nathan Campus, Griffith University, 170, Kessels Rd, Nathan, 4111 Queensland, Australia 
d Botanical Medicine Research Institute, Brisbane, Australia 
e Bioextracts P/L, Brisbane, Australia 

Corresponding author at: School of Environment and Science, Griffith University, 170, Kessels Rd, Nathan, 4111 Queensland, Australia.School of Environment and Science, Griffith University170, Kessels Rd, NathanQueensland4111Australia

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción o una compra individual.

páginas 14
Iconografías 8
Vídeos 0
Otros 0

Abstract

Objective

Syzygium australe (H.L. Wnddl. ex. Link) B. Hyland, Syzygium luehmannii (F. Muell.) L.A.S. Johnson, Syzygium jambos L. (Alston), Terminalia ferdinandiana Exell. and Tasmannia lanceolata (Poir.) A.C.Sm. are used in traditional Australian Aboriginal and Asian healing systems to treat a variety of pathogenic diseases including fungal skin infections, yet they are yet to be examined for the ability to inhibit the growth of human dermatophytes.

Materials and methods

The fungal growth inhibitory activity of extracts produced from selected Australian and Asian plants was assessed against a panel of human dermatophytes by standard disc diffusion and liquid dilution MIC methods. The toxicity of the extracts was evaluated by Artemia lethality and MTS HDF cell viability assays. The phytochemistry of the most promising extracts were examined by GC-MS headspace analysis and some interesting compounds were highlighted.

Results

The aqueous and methanolic extracts of all plant species were good antifungal agents, inhibiting the growth of all of the dematophytes tested. The methanolic Saustrale (SA) and S. luehmannii (SL) extracts were particularly potent fungal growth inhibitors. MIC values of 39 and 53μg/mL were recorded for the methanolic SL fruit extract against T. mentagrophytes and T. rubrum respectively. Similar MICs were also noted for the methanolic SL leaf extract (88 and 106μg/mL respectively). The methanolic SL leaf extract was a particularly good fungal growth inhibitor, with MIC values100μg/mL against the reference C. albicans strain (96μg/mL), E. floccosum (53μg/mL), and T. mentagrophytes (88μg/mL). This extract also produced MICs200μg/mL against all other fungal species/strains tested. Similarly good activity was seen for the methanolic S. australe leaf and fruit extracts, as well as the S. lehmannii fruit and S. jambos leaf extracts, with MIC values 100-500μg/mL. Interestingly, these extracts had low toxicity and high therapeutic indices, indicating their suitability for clinical use. GC-MS headspace analysis highlighted several monoterpenoids and sesquiterpenoids in the methanolic SA and SL extracts. T. ferdinandiana and T. lanceolata extracts also had promising antifungal activity, albeit with substantially higher MICs.

Conclusion

Whilst multiple extracts inhibited fungal growth, the methanolic S. australe and S. luehmannii leaf extracts and the S. luehmannii fruit extracts showed particularly potent activity against each of these dermatophytes, indicating that they are promising leads for the development of anti-dermatophytic therapeutics.

El texto completo de este artículo está disponible en PDF.

Keywords : Tinea pedis, Onychomyosis, Ringworm, Candida albicans, Dermatophytosis, Traditional medicine, Syzygium, Kakadu plum


Esquema


© 2019  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 29 - N° 4

P. 331-344 - décembre 2019 Regresar al número
Artículo precedente Artículo precedente
  • Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures
  • C. Sriphannam, N. Nuanmuang, K. Saengsawang, D. Amornthipayawong, A. Kummasook
| Artículo siguiente Artículo siguiente
  • Biochemical and cellular activity of chemically synthesized elastase inhibitor (S-AFUEI) from Aspergillus fumigatus
  • Y. Fukui, Y. Okumura, K. Uchiya, Y. Komori, K. Ogawa, T. Nikai, Y. Hasegawa

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción o una compra individual.

El acceso al texto completo de este artículo requiere una suscripción o una compra individual

¿Ya suscrito a @@106933@@ revista ?

;

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.